Comas’ group reported that in high metastatic cells Sema3F expression is under the control of c-myc/Id2 pathway, and that Id2 enhanced migratory and invasive ability of melanoma cells through downregulation of Sema3F in a neuropilin2 dependent manner. The gene discussed is ID2; the disease is melanoma.